Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection
2016
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88†
2008
The gut microbiota and host health: a new clinical frontier
2015 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis
2009
Acute kidney injury
2012 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2018 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites
2016
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension
2009
Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis
2014
Human Genetics Shape the Gut Microbiome
2014 Standout
NOX in liver fibrosis
2007
Liver cirrhosis
2014
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
2015
Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal Bleeding
2009
Gut biogeography of the bacterial microbiota
2015 Standout
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Inflammation and portal hypertension – The undiscovered country
2014
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
2012
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3
2010
Acute-on chronic liver failure
2012
Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression
2012
Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2012 StandoutNobel
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Renal Failure in Cirrhosis
2009
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
2015
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Acute-on-chronic liver failure in cirrhosis
2016
Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients
2009
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease
2012
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
2011
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Gut microbiome, liver immunology, and liver diseases
2020
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
2015
Gut microbiome and health: mechanistic insights
2022 Standout
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
2010
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Acute kidney injury
2019 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Vascular endothelial dysfunction in cirrhosis
2007
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis
2015
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
2015
Hepatorenal Disorders
2015
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Acute-on-chronic Liver Failure
2016
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Meta‐analysis: antioxidant supplements for liver diseases – the Cochrane Hepato‐Biliary Group
2010
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
2015
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts
2008
Early Enteral Feeding, Compared With Parenteral, Reduces Postoperative Septic Complications The Results of a Meta-Analysis
1992 Standout
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic review
2011
The microbiota in cirrhosis and its role in hepatic decompensation
2021
Inflammasome activation and function in liver disease
2015
Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol
2011
Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis
2010
Interactions Between the Intestinal Microbiome and Liver Diseases
2014
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration
2010
Gut microbiota-related complications in cirrhosis
2014
Alcoholic steatohepatitis
2010
The human microbiome: at the interface of health and disease
2012 Standout
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function
2013
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus
2017
The potential for caspases in drug discovery.
2010
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
The Hidden World within Plants: Ecological and Evolutionary Considerations for Defining Functioning of Microbial Endophytes
2015 Standout
The interleukin-17 pathway is involved in human alcoholic liver disease # †
2008
Hemodynamic Phenotype of the Failing Fontan in an Adult Population
2013
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Introduction to the human gut microbiota
2017 Standout
Alcoholic Hepatitis
2009
Inflammatory Bowel Disease
2010 Standout
Metagenomics of the Human Body
2010
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Large intestine permeability is increased in patients with compensated liver cirrhosis
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
2010
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
2013
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Updates on Hepato-Renal Syndrome
2013
Gut Microbiota and Host Reaction in Liver Diseases
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites
2014
Works of Pablo Bellot being referenced
Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long‐term results of a randomized multicentre study
2007
Hepatic Expression of Candidate Genes in Patients With Alcoholic Hepatitis: Correlation With Disease Severity
2006
Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin
2007
Primary prophylaxis of esophageal variceal bleeding in cirrhosis
2008
Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis
2008
Norfloxacin Modulates the Inflammatory Response and Directly Affects Neutrophils in Patients With Decompensated Cirrhosis
2009
Interleukin-10–Mediated Heme Oxygenase 1–Induced Underlying Mechanism in Inflammatory Down-Regulation by Norfloxacin in Cirrhosis §δ
2010
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
2006
Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites
2010
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd‐Chiari syndrome†
2005
Influence of beta‐2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis†
2005
NCX-1000, a Nitric Oxide–Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study
2009
Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis
2014
A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis
2008
Bacterial DNA Translocation Is Associated With Systemic Circulatory Abnormalities and Intrahepatic Endothelial Dysfunction in Patients With Cirrhosis
2010
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir‐based therapy
2016
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
2012
[236] ACUTE HVPG RESPONSE TO I. V. PROPRANOLOL AND RISK OF PORTAL HYPERTENSION RELATED BLEEDING
2007